Thopaz for PALs Evaluation

Not yet recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Persistent Air Leaks
Interventions
DIAGNOSTIC_TEST

Persistent air leak quantification

"In this trial, patients with PALs will have their chest tubes connected to the Thopaz+ system. The Thopaz+ will continuously quantify the volume of air leaks, providing real-time data for analysis.~Data from both the Thopaz+ and standard serial occlusion test with Fogarty balloon will be combined and integrated to provide a comprehensive assessment of the air leak source. The bronchoscopic will perform standard visual assessment of changes in air leak during serial balloon occlusion in order to identify the best region for endobronchial treatments; use of measurements from the Thopaz and serial balloon occlusion test will be allowed as part of clinical reasoning but are not required to be used by the treating clinician."

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Kai Swenson

OTHER

NCT07105436 - Thopaz for PALs Evaluation | Biotech Hunter | Biotech Hunter